Robert Ballotti

Robert Ballotti

Auto-generated profile, based on publicly available information

Robert Ballotti

Université Côte d’Azur, Nice, France

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in Pigment Cell Research
Verified
Journal Article
Open access
PDF file
RBRoser Buscà
Roser Buscà
RBRobert Ballotti
Robert Ballotti
Compelling evidence has been gathered indicating that pro‐opiomelanocortin peptides, α‐melanocyte stimulating hormone (α‐MSH) and adrenocorticotropic hormone (ACTH), through the cyclic AMP pathway, play a pivotal role in melanocyte differentiation and in the regulation of melanogenesis. Recently, the molecular events linking cAMP to melanogenesis up‐regulation have been elucidated. This cascade involves the activation of protein kinase A and CREB transcription factor, leading to the up‐regulation of the expression of Microphthalmia associated transcription factor (MITF). MITF has been found mutated in patients with Waardenburg syndrome 2A, and plays a crucial role in melanocyte development. MITF binds and activates melanogenic gene promoters, thereby increasing their expression which results in an increased melanin synthesis. Beyond this simplified scheme, It appears that melanogenic gene expression is controlled by a complex network of regulation involving other transcription factors such as Brn2, TBX2, PAX3 and SOX10. Further studies are required to better understand the respective roles of these factors in the regulation of melanin synthesis. In addition, other intracellular signaling pathways, like the phosphatidyl inositol 3‐kinase pathway, as well as the molecular cascade of events governed by the small GTP‐binding protein Rho, seem to be involved in the regulation of melanogenesis and melanocyte dendricity. Finally, it should be mentioned that cAMP activates a melanocyte‐specific pathway leading to MAP kinase activation. MAP kinase, ERK2, phosphorylates MITF, thereby targeting the transcription factor to proteasomes for degradation. Thus, in addition to the complex transcriptional regulation, melanogenesis is also subjected to a post‐translational regulation that controls MITF or tyrosinase function. Taken together, these complex molecular processes would finally allow a fine tuning of melanocyte differentiation leading to melanin synthesis.

19 October 2011 in Nature
Verified
Journal Article
Closed access
PDF file
CBCorine Bertolotto
Corine Bertolotto
FLFabienne Lesueur
Fabienne Lesueur
SGSandy Giuliano
Sandy Giuliano
TSThomas Strub
Thomas Strub
MLMahaut de Lichy
Mahaut de Lichy
BPBrigitte Bressac-de Paillerets
Brigitte Bressac-de Paillerets

10 August 1998 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CBCorine Bertolotto
Corine Bertolotto
PAPatricia Abbe
Patricia Abbe
THTimothy J. Hemesath
Timothy J. Hemesath
KBKarine Bille
Karine Bille
DFDavid E. Fisher
David E. Fisher
RBRobert Ballotti
Robert Ballotti
Melanocyte differentiation characterized by an increased melanogenesis, is stimulated by α-melanocyte–stimulating hormone through activation of the cAMP pathway. During this process, the expression of tyrosinase, the enzyme that controls melanin synthesis is upregulated. We previously showed that cAMP regulates transcription of the tyrosinase gene through a CATGTG motif that binds microphthalmia a transcription factor involved in melanocyte survival. Further, microphthalmia stimulates the transcriptional activity of the tyrosinase promoter and cAMP increases the binding of microphthalmia to the CATGTG motif. These observations led us to hypothesize that microphthalmia mediates the effect of cAMP on the expression of tyrosinase. The present study was designed to elucidate the mechanism by which cAMP regulates microphthalmia function and to prove our former hypothesis, suggesting that microphthalmia is a key component in cAMP-induced melanogenesis. First, we showed that cAMP upregulates the transcription of microphthalmia gene through a classical cAMP response element that is functional only in melanocytes. Then, using a dominant-negative mutant of microphthalmia, we demonstrated that microphthalmia is required for the cAMP effect on tyrosinase promoter. These findings disclose the mechanism by which cAMP stimulates tyrosinase expression and melanogenesis and emphasize the critical role of microphthalmia as signal transducer in cAMP-induced melanogenesis and pigment cell differentiation.

25 November 2009 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
PDF file
YCYann Cheli
Yann Cheli
MOMickael Ohanna
Mickael Ohanna
RBRobert Ballotti
Robert Ballotti
CBCorine Bertolotto
Corine Bertolotto

1 February 1998 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
CBCorine Bertolotto
Corine Bertolotto
RBRoser Buscà
Roser Buscà
PAPatricia Abbe
Patricia Abbe
KBKarine Bille
Karine Bille
EAEdith Aberdam
Edith Aberdam
RBRobert Ballotti
Robert Ballotti
In melanocytes and in melanoma cells, cyclic AMP (cAMP)-elevating agents stimulate melanogenesis and increase the transcription of tyrosinase, the rate-limiting enzyme in melanin synthesis. However, two other enzymes, tyrosinase-related protein 1 (TRP1) and TRP2, are required for a normal melanization process leading to eumelanin synthesis. In B16 melanoma cells, we demonstrated that stimulation of melanogenesis by cAMP-elevating agents results in an increase in tyrosinase, TRP1, and TRP2 expression. cAMP, through a cAMP-dependent protein kinase pathway, stimulates TRP1 and TRP2 promoter activities in both B16 mouse melanoma cells and normal human melanocytes. Regulation of the TRP1 and TRP2 promoters by cAMP involves a M box and an E box. Further, a classical cAMP response element-like motif participates in the cAMP responsiveness of the TRP2 promoter, demonstrating that the TRP2 gene is subjected to different regulatory processes, which could account for its different expression patterns during embryonic development or under specific physiological and pathological conditions. We also found that microphthalmia, a basic helix-loop-helix transcription factor, strongly stimulates the transcriptional activities of the TRP1 and TRP2 promoters, mainly through binding to the M boxes. Additionally, we demonstrated that cAMP increases microphthalmia expression and thereby its binding to TRP1 and TRP2 M boxes. These convergent and compelling results disclose at least a part of the molecular mechanism involved in the regulation of melanogenic gene expression by cAMP and emphasize the pivotal role of microphthalmia in this process.

24 January 2011 in Oncogene
Verified
Journal Article
Closed access
TSThomas Strub
Thomas Strub
SGS Giuliano
S Giuliano
TYT Ye
T Ye
CBC Bonet
C Bonet
CKC Keime
C Keime
IDI Davidson
I Davidson